Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.24 USD | +3.46% |
|
-24.32% | +26.55% |
27/06 | BMO Initiates Taysha Gene Therapies at Outperform With $5 Price Target | MT |
26/06 | Taysha Gene Therapies Prices $75 Million Offering of Shares, Pre-Funded Warrants; Shares Fall | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+26.55% | 45Cr | |
+19.41% | 4.55TCr | |
+38.65% | 3.94TCr | |
-8.62% | 3.85TCr | |
+26.95% | 3.07TCr | |
-13.50% | 2.6TCr | |
+10.74% | 2.59TCr | |
+44.87% | 1.41TCr | |
+34.36% | 1.27TCr | |
-7.14% | 1.13TCr |
- Stock Market
- Equities
- TSHA Stock
- News Taysha Gene Therapies, Inc.
- BMO Initiates Taysha Gene Therapies at Outperform With $5 Price Target